From Yahoo Board:Rooneys Response to email
To: investor@positron.com<investor@positron.com>;
Hello,
I’m a very concerned investor with over 160,000 shares. I feel great about Positrons technology and partnership, and feel Positron is on the verge of a paradigm shift in the radiopharmaceuticals industry with the Pharm-Assist and technologies. I also think Positron could be a leader in this industry someday.
However, I, and many other investors are very concerned about the increase of shares outstanding in the last year. This comes right off the sec documents:
Aug 23, 2010 10-Q
Shares Outstanding: 773,452,547
Aug 14, 2009 10-Q
Shares Outstanding: 212,316,863
Obviously I feel the shares I bought have been diluted, and I would like to know the reason for the massive dilution. Will this continue, will the dilution stop? I think these are valid questions that should be answered.
HI Lou,
We are very aware of the increase in shares and have only increased the share issuance to operate, get 100% cleaned up on the debt and grow. This is how you get award winning products and partners/alliances that change the world with and for you.
You will see in 2009 that the cash was very low. This is not the case today. We are selling PET products and launching pharma products through our dispensing technologies and actual pharmaceuticals are on the short term horizon.
Any dilution has been 100% attributed to growth and growth of a healthier company.
We only issue shares to grow existing businesses and as need as we enter into new markets….I believe this expansion has been evident.
The increase in our value as a company is much greater than any increase.
Please let me know if this helps.
Thank you
Patrick Rooney
Positron Corporation
CEO
